HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicolino Ruperto Selected Research

Osteocalcin

3/2015Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: results from a phase III trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicolino Ruperto Research Topics

Disease

71Juvenile Arthritis (Juvenile Idiopathic Arthritis)
03/2024 - 07/2004
25Arthritis (Polyarthritis)
12/2023 - 08/2003
12Dermatomyositis (Dermatopolymyositis)
11/2023 - 09/2004
11Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 09/2004
10Infections
11/2021 - 12/2012
9Fever (Fevers)
11/2023 - 11/2004
8Psoriatic Arthritis
05/2023 - 01/2011
7Myositis (Idiopathic Inflammatory Myopathies)
11/2023 - 09/2005
7Body Weight (Weight, Body)
01/2021 - 02/2005
6Pain (Aches)
01/2022 - 12/2007
6Inflammation (Inflammations)
11/2018 - 12/2007
4Familial Mediterranean Fever (Periodic Disease)
11/2023 - 05/2013
4Mevalonate Kinase Deficiency
11/2023 - 05/2013
4Uveitis
01/2023 - 08/2003
3Pharyngitis (Sore Throat)
11/2023 - 09/2011
3Lymphadenitis (Adenitis)
11/2023 - 05/2013
3Neoplasms (Cancer)
05/2023 - 06/2014
3Macrophage Activation Syndrome
01/2022 - 12/2012
3Cryopyrin-Associated Periodic Syndromes
01/2022 - 05/2013
3Necrosis
01/2022 - 08/2008
3Rheumatic Diseases (Rheumatism)
12/2020 - 01/2008
2Aphthous Stomatitis (Aphthous Ulcer)
11/2023 - 04/2018
2Polymyositis
11/2023 - 11/2011
2Exanthema (Rash)
10/2023 - 11/2004
2Negative rheumatoid factor polyarthritis
11/2021 - 01/2011
2Rheumatoid Arthritis
10/2021 - 06/2015
2Proteinuria
01/2021 - 05/2010
2Abdominal Pain (Pain, Abdominal)
01/2021 - 05/2010
2Neutropenia
01/2019 - 12/2012
2Injection Site Reaction
01/2018 - 02/2012
2Splenomegaly
10/2017 - 11/2004
2Hypertriglyceridemia
04/2011 - 11/2009
2Hyperferritinemia
04/2011 - 11/2009
1Breakthrough Infections
12/2023
1Pulmonary Embolism
12/2023
1Tuberculosis (Tuberculoses)
05/2023
1Hodgkin Disease (Hodgkin's Disease)
05/2023
1Disease Progression
01/2023
1Axial Spondyloarthritis
01/2023
1Skin Manifestations
01/2023
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1Drug-Related Side Effects and Adverse Reactions
01/2022
1Adult-Onset Still's Disease
11/2020
1Diphtheria
02/2020
1Tetanus
02/2020
1Spondylitis
01/2019

Drug/Important Bio-Agent (IBA)

25Methotrexate (Mexate)FDA LinkGeneric
11/2023 - 07/2004
13Abatacept (Orencia)FDA Link
01/2024 - 08/2008
11Etanercept (Enbrel)FDA Link
11/2023 - 02/2013
10tocilizumab (atlizumab)FDA Link
03/2024 - 12/2012
8C-Reactive ProteinIBA
11/2023 - 11/2004
7Adrenal Cortex Hormones (Corticosteroids)IBA
09/2022 - 08/2003
7canakinumabFDA Link
01/2021 - 02/2012
6Antirheumatic Agents (DMARD)IBA
12/2023 - 08/2008
6GlucocorticoidsIBA
01/2023 - 12/2012
5Prednisone (Sone)FDA LinkGeneric
09/2019 - 02/2016
4Rheumatoid FactorIBA
12/2023 - 01/2019
4Rituximab (Mabthera)FDA Link
11/2023 - 01/2017
4Adalimumab (Humira)FDA Link
11/2022 - 08/2008
4ametantrone (HAQ)IBA
01/2021 - 12/2007
4Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2019 - 02/2016
4Proteins (Proteins, Gene)FDA Link
01/2019 - 06/2014
3amsonic acid (DAS)IBA
01/2024 - 11/2011
3Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2022 - 05/2010
3tofacitinibIBA
01/2022 - 12/2017
3ColchicineFDA LinkGeneric
01/2021 - 11/2016
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2019 - 08/2008
3Antinuclear AntibodiesIBA
01/2019 - 08/2003
3Biomarkers (Surrogate Marker)IBA
01/2018 - 12/2012
3Infliximab (Remicade)FDA Link
09/2010 - 09/2007
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2023 - 01/2019
2secukinumabIBA
11/2023 - 01/2023
2Tumor Necrosis Factor InhibitorsIBA
02/2023 - 09/2019
2HLA-B27 Antigen (HLA B27 Antigen)IBA
11/2022 - 08/2003
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2022 - 11/2016
2Interleukin-1 (Interleukin 1)IBA
01/2022 - 12/2012
2golimumabFDA Link
10/2021 - 01/2018
2belimumabIBA
01/2021 - 10/2020
2Ferritins (Ferritin)IBA
10/2019 - 10/2014
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2019 - 11/2009
2Fibrinogen (Factor I)FDA Link
10/2019 - 10/2017
2Transaminases (Aminotransferases)IBA
11/2016 - 12/2012
22-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
05/2013 - 11/2011
1baricitinibIBA
12/2023
1Janus Kinase 1IBA
12/2023
1pazelliptineIBA
11/2023
1AA amyloidosisIBA
10/2023
1N-phthaloylglutamic acidIBA
01/2022
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2022
1Estrogens (Estrogen)FDA Link
01/2021
1Diphtheria-Tetanus VaccineIBA
02/2020
1VaccinesIBA
02/2020
1SteroidsIBA
09/2019
1CreatinineIBA
01/2019
1Synthetic DrugsIBA
12/2018
1AutoantibodiesIBA
11/2018

Therapy/Procedure

28Therapeutics
12/2023 - 08/2003
3Drug Therapy (Chemotherapy)
01/2023 - 01/2011
2Injections
01/2018 - 08/2003
1Drug Tapering
12/2020